Korro Bio Inc.
Organization details
- Legal name
- Korro Bio Inc.
- Former names
- Frequency Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- KRRO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001703647
- EIN
- 47-2324450
Board of directors
- Since 2023
-
David L. Lucchino · Director · President and CEOSince 2023
-
Jean Francois Formela · DirectorSince 2023
-
Katharine Knobil · DirectorSince 2024
-
Nessan Bermingham · DirectorSince 2023
-
Rachel Meyers · DirectorSince 2023
-
Ram Aiyar · Director · President and CEOSince 2023
-
Timothy R. Pearson · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
81.5%
-
82.6%
Board connections
4 of this board's directors also sit on 10 other boards. 10 are in the same sector.
-
Black Diamond Therapeutics Inc. Same sectorvia Ali Behbahani
-
CRISPR Therapeutics AG Same sectorvia Ali Behbahani
-
CVRx Inc. Same sectorvia Ali Behbahani
-
Crescent Biopharma Inc. Same sectorvia Timothy R. Pearson
-
ImageneBio Inc. Same sectorvia Jean Francois Formela
-
Marker Therapeutics Inc. Same sectorvia Katharine Knobil
-
Monte Rosa Therapeutics Inc. Same sectorvia Ali Behbahani
-
Nkarta Inc. Same sectorvia Ali Behbahani
-
Pliant Therapeutics Inc. Same sectorvia Katharine Knobil
-
SpyGlass Pharma Inc. Same sectorvia Ali Behbahani
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $21,677,007
- 16 purchases by 11 insiders
- Sold, last 12 months
- $5,698,797
- 33 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 26, 2026 | Lynx1 Capital Management LP 10% owner | Open-market purchase | +25,124 | $11.75 | $295,091 |
| Oct 23, 2026 | Lynx1 Capital Management LP 10% owner | Open-market purchase | +2,510 | $12.11 | $30,386 |
| Oct 22, 2026 | Lynx1 Capital Management LP 10% owner | Open-market purchase | +12,175 | $9.68 | $117,810 |
| Oct 22, 2026 | Lynx1 Capital Management LP 10% owner | Open-market purchase | +40,000 | $11.04 | $441,464 |
| Sep 14, 2026 | Jean Francois Formela Director | Open-market sale | −31,888 | $14.12 | $450,259 |
| Sep 14, 2026 | Jean Francois Formela Director | Open-market sale | −6,602 | $14.12 | $93,220 |
| Sep 11, 2026 | Dolan Oliver Officer (Senior Vice President, Finance) | Open-market sale | −5 | $13.72 | $69 |
| Sep 11, 2026 | Jean Francois Formela Director | Open-market sale | −8,450 | $13.99 | $118,216 |
| Sep 11, 2026 | Jean Francois Formela Director | Open-market sale | −1,750 | $13.99 | $24,483 |
| Sep 9, 2026 | Dolan Oliver Officer (Senior Vice President, Finance) | Open-market sale | −6 | $13.60 | $82 |
| Sep 8, 2026 | Dolan Oliver Officer (Senior Vice President, Finance) | Open-market sale | −7,347 | $13.51 | $99,258 |
| Aug 26, 2026 | Jean Francois Formela Director | Open-market sale | −249 | $13.96 | $3,476 |
| Aug 26, 2026 | Jean Francois Formela Director | Open-market sale | −51 | $13.96 | $712 |
| Aug 19, 2026 | Jean Francois Formela Director | Open-market sale | −23,584 | $14.00 | $330,176 |
| Aug 19, 2026 | Jean Francois Formela Director | Open-market sale | −4,884 | $14.00 | $68,376 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Korro Bio Inc.
Who is the CEO of Korro Bio Inc.?
Ram Aiyar has been Korro Bio Inc.'s President and CEO since November 2023.
How many directors are on Korro Bio Inc.'s board?
Korro Bio Inc.'s board has 8 directors: Ali Behbahani, David L. Lucchino, Jean Francois Formela, Katharine Knobil, Nessan Bermingham, Rachel Meyers, Ram Aiyar and Timothy R. Pearson.
Are Korro Bio Inc. insiders buying or selling shares?
Over the last 12 months, Korro Bio Inc. insiders bought $21.7 million of shares in 16 purchases and sold $5.7 million of shares in 33 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="korro-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.